FDA Adverse Event Malfunction Summary report: N

ACURIS ITE/ WAX GUARD CERU-PROTECT

MDR report key: 3766016 · Received December 19, 2013

Report

Report Number
3005019184-2013-00016
Event Type
Malfunction
Date Received
December 19, 2013
Date of Event
June 2, 2006
Report Date
December 18, 2013
Manufacturer
SIEMENS HEARING INSTRUMENTS, INC.
Product Code
ESD
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MN, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THIS REPORT WAS FILED LATE BECAUSE THE INCIDENT WAS INCORRECTLY CLASSIFIED AS NOT MDR REPORTABLE. A RETROSPECTIVE REVIEW OF COMPLAINTS, HOWEVER, IDENTIFIED THIS INCIDENT AS MDR REPORTABLE. INVESTIGATION AND CONCLUSION: AN INVESTIGATION OF THE RETURNED DEVICE REVEALED THAT THE WAX GUARD EXTENDS 0.1-0.2 MM BEYOND THE CUSTOM SHELL RESULTING IN A PULL FORCE ON THE GUARD WHEN REMOVING THE INSTRUMENT FROM THE TIGHT EAR CANAL OF THIS PARTICULAR INDIVIDUAL. THIS SITUATION IS RESULTING FROM NA INCORRECT SHELL PRODUCTION. THE BORE FOR THE WAX GUARD SHOULD BE DEEP ENOUGH TO ALLOW FOR THE WAX GUARD TO BE COMPLETELY EMBEDDED IN THE ITE SHELL. AS A RESULT THE PRODUCTION PERSONNEL WAS NOTIFIED ABOUT THE INCIDENT AND INSTRUCTED HOW TO PERFORM SHELL PRODUCTION TO PROVIDE FOR A CORRECT AND TIGHT FIT OF THE CERU-PROTECT. THE PATIENT RECEIVED A REPAIRED DEVICE. THE WORK INSTRUCTION FOR THIS PRODUCTION STEP WAS UPDATED TO PROVIDE FOR A CORRECT INSTALLATION OF THE WAX GUARD AND INCLUDES THE INSTRUCTION TO VERIFY THE PROPER FIT.

Description of Event or Problem · 1

A PATIENT IN (B)(6) WAS WEARING HIS ACURIS ITE HEARING AID ON HIS RIGHT EAR, CONTAINING A WAX GUARD (C-GUARD). THE WAX GUARD SEPARATED FROM THE SHELL AND REMAINED IN THE PATIENT'S EAR CANAL. A HEARING HEALTH PROFESSIONAL REMOVED THE C-GUARD FORM THE PATIENT'S EAR CANAL WITHOUT INJURY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
667415 ACURIS ITE/ WAX GUARD CERU-PROTECT IN THE EART HEARING AID ESD SIEMENS HEARING INSTRUMENTS, INC.

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention